RESUMEN
The structure of hexanuclear 6-methyl-2-pyridinethiolato copper(I) [Cu6(6-mpyt)(6)] crystals has been studied by the X-ray diffraction analysis. These crystals show highly efficient luminescence whose color changes drastically from red to green-blue with lowering temperature from room temperature (RT) to liquid nitrogen temperature (LNT). This is a new example of luminescence thermochromism for hexanuclear copper(I) cluster compounds. Two relaxed luminescence bands appear predominantly: one (CC-band), red luminescence appearing in the lower-energy region around 1.8 eV at higher temperature, is assigned to the transition between intramolecular orbitals (MO) of a Cu cluster center (CC), and the other (CT-band), green-blue luminescence appearing at the higher energy side of 2.6 eV than the CC-band at lower temperature, is assigned to a charge transfer (CT) transition from the CC-MO to a ligand MO. Additionally, the CT band can be deconvoluted to two subbands CT(L) and CT(H). The intensities of the CC- and the CT-bands change complementarily with temperature via a thermal activation process, giving the thermochromism. All of these band shapes can be fitted by a Gaussian function, and their widths are fairly large obeying the hyperbolic cotangent law. These features reflect our system to be a strong electron-lattice coupling one. The relaxation process of the photoexcited states is discussed in terms of a configuration coordinate model.
RESUMEN
We report a case of chronic thromboembolic pulmonary hypertension based on essential thrombocythemia. A 72-year-old woman was admitted to our hospital with dyspnea. The hematologic workup revealed a platelet count of 99.2 x 10(4)/microliter. Chest radiographic examination revealed cardiomegaly with bilateral pulmonary artery enlargement. A perfusion lung scan suggested and pulmonary angiography confirmed--multiple pulmonary embolism. Pulmonary artery pressure was 90/30 (51) mmHg. Thrombolytic therapy was performed successfully, and a diagnosis of essential thrombocythemia was made on the basis of the criteria proposed by the Polycythemia Vera Study Group. The therapy of essential thrombocythemia including ranimustine was effective, and one year later, the essential thrombocythemia and chronic respiratory failure had improved. To our knowledge, this case of chronic thromboembolic pulmonary hypertension based on essential thrombocythemia is a very rare one.